Company Description
WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People’s Republic of China and internationally.
The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators.
It also engages in the research and development of biological and medical technology; and sale of chemical products.
The company serves hospitals, pharmacies, and medical institutions. It exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania.
WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.
| Country | China |
| Founded | 2002 |
| IPO Date | Aug 23, 2024 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 238 |
| CEO | Shuang Wu |
Contact Details
Address: No. 2 Tonghuinan Road, Floor 23 Hangzhou China | |
| Phone | 86 571 8261 3568 |
| Website | workmedtech.com |
Stock Details
| Ticker Symbol | WOK |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 1929783 |
| CUSIP Number | G9767H117 |
| ISIN Number | KYG9767H1258 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Shuang Wu | Chairman and Chief Executive Officer |
| Ningfang Liang | Chief Financial Officer |
| Baiming Yu | Chief Operating Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 30, 2026 | 20-F | Annual and transition report of foreign private issuers |
| Jan 5, 2026 | 6-K | Report of foreign issuer |
| Dec 30, 2025 | 6-K | Report of foreign issuer |
| Dec 2, 2025 | 6-K/A | Filing |
| Nov 24, 2025 | 6-K | Report of foreign issuer |
| Nov 24, 2025 | 424B5 | Filing |
| Nov 14, 2025 | SCHEDULE 13G/A | Filing |
| Nov 7, 2025 | 6-K | Report of foreign issuer |
| Nov 7, 2025 | 6-K | Report of foreign issuer |
| Oct 21, 2025 | 6-K | Report of foreign issuer |